Skip to main content
. 1999 May;116(2):340–346. doi: 10.1046/j.1365-2249.1999.00894.x

Table 3.

Transforming growth factor-beta (TGF-β) bioactivity levels in bronchoalveolar lavage fluid (BALF) from idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis (HP) and sarcoidosis (Sarc) patients and healthy controls

graphic file with name cei0116-0340-t3.jpg